Since the upregulation of EGFR is one of the most important biomarkers associated with cancer adverse prognosis, sensitive detection of EGFR-expressing exosomes plays a pivotal role in the early and non-invasive diagnosis of various cancers. The gene discussed is EGFR; the disease is cancer.